• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氮杂蒽二酮诱导实验性肿瘤细胞DNA损伤和细胞毒性的比较。

Comparison of aza-anthracenedione-induced DNA damage and cytotoxicity in experimental tumor cells.

作者信息

Hazlehurst L A, Krapcho A P, Hacker M P

机构信息

Department of Pharmacology, University of Vermont College of Medicine, Burlington, USA.

出版信息

Biochem Pharmacol. 1995 Sep 28;50(7):1087-94. doi: 10.1016/0006-2952(95)00246-v.

DOI:10.1016/0006-2952(95)00246-v
PMID:7575665
Abstract

Aza-anthracenediones are a new class of anti-cancer drugs, which demonstrate promising in vitro and in vivo activity. Our laboratory has synthesized a variety of structural analogs in which we determined previously that the positioning of the nitrogen within the backbone, as well as sidearm modification, results in dramatic differences in the potency of cytotoxicity. We reported previously that although DNA reactivity appears to be a necessary component for mediating cell death, it is not sufficient for predicting cytotoxicity of the aza-anthracenediones. We have chosen three aza-anthracenediones (BBR 2828, BBR 2778 and BBR 2378) to investigate the importance of DNA strand breaks and/or protein-concealed DNA breaks induced by aza-anthracenediones. We determined in the present study that, while all three drugs cause DNA breaks as determined by alkaline and neutral elution, as well as KCl-SDS precipitation, these breaks do not correlate directly with their potency as cytotoxic compounds. Further, we found significant differences in the types of DNA breaks induced by these drugs. Finally, we report that the persistence of protein-DNA complexes induced by all three drugs was similar and, therefore, cannot account for differences in the potency of cytotoxicity of the aza-anthracenediones. Thus, we postulate that, while the total number of drug-induced protein-concealed DNA breaks is an important indicator of drug toxicity, it is possible that the actual nature of the breaks may differ among the aza-anthracenedione congeners, and it is these differences in the actual proteins present in the DNA breaks that differentiate between aza-anthracenediones.

摘要

氮杂蒽二酮是一类新型抗癌药物,在体外和体内均显示出有前景的活性。我们实验室已合成了多种结构类似物,此前我们确定了主链中氮的位置以及侧链修饰会导致细胞毒性效力的显著差异。我们先前报道过,尽管DNA反应性似乎是介导细胞死亡的必要组成部分,但它不足以预测氮杂蒽二酮的细胞毒性。我们选择了三种氮杂蒽二酮(BBR 2828、BBR 2778和BBR 2378)来研究氮杂蒽二酮诱导的DNA链断裂和/或蛋白质掩盖的DNA断裂的重要性。我们在本研究中确定,虽然通过碱性和中性洗脱以及KCl-SDS沉淀测定,所有这三种药物都会导致DNA断裂,但这些断裂与它们作为细胞毒性化合物的效力并不直接相关。此外,我们发现这些药物诱导的DNA断裂类型存在显著差异。最后,我们报道所有这三种药物诱导的蛋白质-DNA复合物的持久性相似,因此不能解释氮杂蒽二酮细胞毒性效力的差异。因此,我们推测,虽然药物诱导的蛋白质掩盖的DNA断裂总数是药物毒性的重要指标,但氮杂蒽二酮同系物之间断裂的实际性质可能不同,正是DNA断裂中存在的实际蛋白质的这些差异区分了氮杂蒽二酮。

相似文献

1
Comparison of aza-anthracenedione-induced DNA damage and cytotoxicity in experimental tumor cells.氮杂蒽二酮诱导实验性肿瘤细胞DNA损伤和细胞毒性的比较。
Biochem Pharmacol. 1995 Sep 28;50(7):1087-94. doi: 10.1016/0006-2952(95)00246-v.
2
Correlation of DNA reactivity and cytotoxicity of a new class of anticancer agents: aza-anthracenediones.一类新型抗癌剂氮杂蒽二酮的DNA反应性与细胞毒性的相关性
Cancer Lett. 1995 May 4;91(1):115-24. doi: 10.1016/0304-3835(95)91035-5.
3
Characterization of anthracenediones and their photoaffinity analogs.蒽醌及其光亲和类似物的表征
Biochem Pharmacol. 2002 Mar 15;63(6):1143-7. doi: 10.1016/s0006-2952(02)00855-9.
4
Bbr 2778, an aza-anthracenedione endowed with preclinical anticancer activity and lack of delayed cardiotoxicity.Bbr 2778,一种具有临床前抗癌活性且无迟发性心脏毒性的氮杂蒽二酮。
Tumori. 2001 Nov-Dec;87(6):407-16. doi: 10.1177/030089160108700611.
5
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives.2-氮杂以及2-氮杂氧化物-蒽二酮衍生物的拓扑异构酶II DNA切割刺激作用、DNA结合活性、细胞毒性及物理化学性质
Mol Pharmacol. 1995 Jul;48(1):30-8.
6
Physicochemical properties, cytotoxic activity and topoisomerase II inhibition of 2,3-diaza-anthracenediones.2,3-二氮杂蒽二酮的物理化学性质、细胞毒性活性及对拓扑异构酶II的抑制作用
Biochem Pharmacol. 1997 Jan 24;53(2):161-9. doi: 10.1016/s0006-2952(96)00646-6.
7
Anthracenedione-methionine conjugates are novel topoisomerase II-targeting anticancer agents with favorable drug resistance profiles.蒽醌二酮-蛋氨酸缀合物是新型拓扑异构酶 II 靶向抗癌药物,具有良好的耐药谱。
Biochem Pharmacol. 2012 May 1;83(9):1208-16. doi: 10.1016/j.bcp.2012.01.025. Epub 2012 Jan 25.
8
A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts.一种对人前列腺癌异种移植瘤有效的新型9-氮杂蒽并吡唑。
Oncology. 2001;61(3):234-42. doi: 10.1159/000055380.
9
Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene.蒽环类抗癌药物米托蒽醌和比生群在白血病L1210细胞中的比较分子药理学
Cancer Res. 1985 Oct;45(10):4915-20.
10
Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.10-[二乙氨基丙基氨基]-6-甲基-5H-吡啶并[3',4':4,5]吡咯并[2,3-g]异喹啉在培养的L1210细胞和分离细胞核中产生与蛋白质相关的DNA断裂:与其他拓扑异构酶II抑制剂的比较。
Cancer Res. 1988 Mar 15;48(6):1404-9.

引用本文的文献

1
Pixantrone Sensitizes Gram-Negative Pathogens to Rifampin.比沙可啶使革兰氏阴性病原体对利福平敏感。
Microbiol Spectr. 2022 Dec 21;10(6):e0211422. doi: 10.1128/spectrum.02114-22. Epub 2022 Nov 1.
2
A Survey of Synthetic Routes and Antitumor Activities for Benzo[]quinoxaline-5,10-diones.苯并[ ]喹喔啉-5,10-二酮的合成路线及抗肿瘤活性研究综述。
Molecules. 2020 Dec 14;25(24):5922. doi: 10.3390/molecules25245922.
3
Mechanisms of Action and Reduced Cardiotoxicity of Pixantrone; a Topoisomerase II Targeting Agent with Cellular Selectivity for the Topoisomerase IIα Isoform.
匹杉琼的作用机制及降低的心脏毒性;一种对拓扑异构酶IIα同工型具有细胞选择性的拓扑异构酶II靶向剂
J Pharmacol Exp Ther. 2016 Feb;356(2):397-409. doi: 10.1124/jpet.115.228650. Epub 2015 Dec 11.
4
Pixantrone induces cell death through mitotic perturbations and subsequent aberrant cell divisions.匹杉琼通过有丝分裂扰动和随后的异常细胞分裂诱导细胞死亡。
Cancer Biol Ther. 2015;16(9):1397-406. doi: 10.1080/15384047.2015.1070979.
5
Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas.匹杉琼用于治疗复发或难治性侵袭性非霍奇金B细胞淋巴瘤的成年患者。
Onco Targets Ther. 2014 May 29;7:865-72. doi: 10.2147/OTT.S34055. eCollection 2014.
6
Initial testing (stage 1) of the topoisomerase II inhibitor pixantrone, by the pediatric preclinical testing program.儿科临床前试验计划对拓扑异构酶 II 抑制剂比沙酮进行初步测试(第 1 阶段)。
Pediatr Blood Cancer. 2014 May;61(5):922-4. doi: 10.1002/pbc.24800. Epub 2013 Oct 26.
7
Synthesis and antitumor evaluation of 6-aryl-substituted benzo[j]phenanthridine- and benzo[g]pyrimido[4,5-c]isoquinolinequinones.6-芳基取代苯并[j]菲啶-和苯并[g]嘧啶并[4,5-c]异喹啉醌的合成及抗肿瘤活性评价。
Molecules. 2012 Sep 28;17(10):11616-29. doi: 10.3390/molecules171011616.
8
CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity.CpG 甲基化增强了匹杉琼和阿霉素诱导的 DNA 损伤,并且是药物敏感性的一个标志物。
Nucleic Acids Res. 2009 Oct;37(19):6355-70. doi: 10.1093/nar/gkp700. Epub 2009 Aug 31.
9
Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent.匹杉琼可被甲醛激活,生成一种强效的DNA加合物形成剂。
Nucleic Acids Res. 2007;35(11):3581-9. doi: 10.1093/nar/gkm285. Epub 2007 May 5.